In one of the largest series (7), six patients with ATC and two patients with poorly differentiated thyroid cancer (all at stage IVC and with BRAF wild-type) were treated with the L+P combination after surgical intervention, followed by EBRT and systemic chemotherapy. This evidence concerns the gene BRAF and thyroid cancer.